Cure My Disease

Don't miss your cure!

 Log in / Sign up

Glaucoma drug could offer simple fix for Graves' eye bulging

NCT ID NCT03708627

Recruiting now Disease control Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study tests whether bimatoprost, a glaucoma eye drop, can reduce bulging eyes in people with Graves' disease. The idea is that the drops may shrink fat around the eye, improving appearance and comfort. Three participants receive one drop in one eye nightly to see if it works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
bimatoprost eye drops
What this could lead to
If it works, this could offer a simple, non-surgical way to reduce eye bulging in Graves' disease.
What could go wrong
This is a very early, tiny trial with only 3 people, so results may not apply widely. Bimatoprost can cause side effects like eye irritation or darkening of the eyelid skin.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GRAVES OPHTHALMOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

endocrine exophthalmos Graves Ophthalmopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GRAVES OPHTHALMOPATHY

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Washington

    RECRUITING

    Seattle, Washington, 98104, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.